0000899243-20-017514.txt : 20200623 0000899243-20-017514.hdr.sgml : 20200623 20200623195442 ACCESSION NUMBER: 0000899243-20-017514 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200619 FILED AS OF DATE: 20200623 DATE AS OF CHANGE: 20200623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stylli Harry CENTRAL INDEX KEY: 0001329344 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39334 FILM NUMBER: 20983530 MAIL ADDRESS: STREET 1: 3595 JOHN HOPKINS CT CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENITY, INC. CENTRAL INDEX KEY: 0001580063 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 273950390 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4330 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 855-293-2639 MAIL ADDRESS: STREET 1: 4330 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: ASCENDANT MDX, INC. DATE OF NAME CHANGE: 20130625 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-19 0 0001580063 PROGENITY, INC. PROG 0001329344 Stylli Harry C/O PROGENITY, INC. 4330 LA JOLLA VILLAGE DRIVE, SUITE 200 SAN DIEGO CA 92122 1 1 1 0 Chairman & CEO Common Stock 2020-06-19 4 P 0 33333 15.00 A 1038635 D Common Stock 2020-06-23 4 C 0 13213254 A 14251889 D Common Stock 2020-06-23 4 C 0 202080 A 14453969 D Series A Preferred Stock 2020-06-23 4 C 0 4120000 0.00 D Common Stock 13213254 0 D Series B Preferred Stock 2020-06-23 4 C 0 1122222 0.00 D Common Stock 202080 0 D On June 19, 2020, the Reporting Person purchased 33,333 shares of the Issuer's common stock at a price of $15.00 per share in the Issuer's initial public offering. Includes 239,074 restricted stock units. The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-3.207 basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a 0.18007-for-one basis immediately prior to the closing of the Issuer's initial public offering. The conversion rate of the Series B Preferred Stock was adjusted pursuant to the Issuer's seventh amended and restated certificate of incorporation because the public offering price per share of common stock in the Issuer's initial public offering was less than $16.68. /s/ Clarke Neumann, Attorney-in-Fact for Harry Stylli 2020-06-23